
Cefnid T 250mg/31.25mg Injection
Marketer
Parenteral Drugs India Ltd
Salt Composition
Ceftriaxone (250mg) + Tazobactum (31.25mg)
Overview Cefnid T 250mg/31.25mg Injection
Cefnid T 250 mg/31.25 mg Injectable solution is a dual-action antibiotic used to combat diverse bacterial infections. Its mechanism inhibits microbial proliferation, thereby curbing infection spread. Administration must always be under medical guidance. Strict adherence to the prescribed dosage schedule is crucial; completing the entire course is vital, regardless of symptom improvement. Premature cessation can compromise treatment effectiveness. Typical side effects include nausea, vomiting, diarrhea, and dyspepsia; worsening symptoms necessitate immediate consultation. Allergic reactions (skin rashes, pruritus, edema, respiratory distress) require prompt medical attention. Prior to commencing treatment, inform your physician of all current medications and pre-existing conditions. Pregnant or lactating individuals should seek medical advice before use. Alcohol consumption should be avoided due to potential additive drowsiness. While generally not impairing driving ability, refrain from driving if drowsiness or dizziness occur. Sufficient rest, a nutritious diet, and adequate hydration are recommended for optimal recovery. Your doctor may order blood tests and other assessments to monitor the medication's effects.
Uses of Cefnid T 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Cefnid T 250mg/31.25mg Injection:
Administering this medication will be handled by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Cefnid T 250mg/31.25mg Injection:
- Diarrhea
- Increased liver enzymes
- Allergic reaction
- Rash
How to use Cefnid T 250mg/31.25mg Injection:
This medication will be administered by your physician or registered nurse; self-medication is strictly prohibited.
How Cefnid T 250mg/31.25mg Injection works:
Ceftriaxone/Tazobactam Injection (Cefnid T 250mg/31.25mg) unites two agents: the antibiotic ceftriaxone and the beta-lactamase inhibitor tazobactam. Ceftriaxone's mechanism involves disrupting bacterial cell wall synthesis, hindering their growth and survival. Tazobactam's role is to counteract bacterial resistance, thereby bolstering ceftriaxone's antibacterial efficacy.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions from concurrent use of Cefnid T 250 mg/31.25 mg Injection and alcohol.
PregnancySAFE IF PRESCRIBED
Cefnid T 250 mg/31.25 mg Injection is typically deemed safe for use in pregnancy. Preclinical trials in animals revealed minimal or no harm to the fetus; nevertheless, data from human trials are scarce.
Breast feedingCAUTION
Administering Cefnid T 250 mg/31.25 mg Injection to breastfeeding mothers requires careful consideration. Lactation should be temporarily discontinued throughout the mother's treatment course and until the medication is fully cleared from her system.
DrivingUNSAFE
Administration of Cefnid T 250 mg/31.25 mg Injection can induce drowsiness, visual disturbances, and dizziness. Driving should be avoided if such effects manifest.
KidneyCONSULT YOUR DOCTOR
Insufficient data exists regarding the administration of Cefnid T 250 mg/31.25 mg Injection to individuals with renal impairment. Seek medical advice.
LiverCAUTION
The injectable formulation of Cefnid T (250 mg/31.25 mg) requires careful administration in individuals with significant hepatic impairment. Dosage modification for Cefnid T (250 mg/31.25 mg) injection may be necessary; physician consultation is advised. Altering the dose of Cefnid T (250 mg/31.25 mg) injection is not suggested for patients exhibiting mild or moderate liver dysfunction.
What if you forget to take Cefnid T 250mg/31.25mg Injection :
Should you inadvertently omit a scheduled dose of Cefnid T 250 mg/31.25 mg Injection, seek immediate medical advice.
Facts to Know About Cefnid T 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Infectious Disease Treatments |
